Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled Study of Insulin Absorption in Healthy Volunteers After Single-dose Oral Administration of Insulin in Dextran Matrix

NCT01114750 is registered in ClinicalTrials.gov with Bows Pharmaceuticals AG as lead sponsor.

NCT NCT01114750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01114750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled Study of Insulin Absorption in Healthy Volunteers After Single-dose Oral Administration of Insulin in Dextran Matrix
Lead sponsor
Bows Pharmaceuticals AG
Phase
Phase 1
Overall status
Suspended
Start date
April 30, 2010
Completion date
October 31, 2010
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus